Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5993)
All Articles published online
|
Jan 28, 2008 (publication date) through Feb 18, 2025
Times Cited of This Article
- Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wang DR, Tang D. Hypermethylated |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i4/524.htm |
| Number | Citing Articles |
| 1 |
Current World Literature. Current Opinion in Lipidology 2008; 19(6): 600 doi: 10.1097/MOL.0b013e32831b7581
|
| 2 |
S. L. Rasmussen, H. B. Krarup, K. G. Sunesen, I. S. Pedersen, P. H. Madsen, O. Thorlacius‐Ussing. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review. Colorectal Disease 2016; 18(6): 549 doi: 10.1111/codi.13336
|
| 3 |
Chi Chun Wong, Weilin Li, Bertina Chan, Jun Yu. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Seminars in Cancer Biology 2019; 55: 90 doi: 10.1016/j.semcancer.2018.04.002
|
| 4 |
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10709
|
| 5 |
Yi Liu, Guodong Zhao, Jin Miao, Hui Li, Yong Ma, Xiaoyu Liu, Shiming Li, Yun Zhu, Shangmin Xiong, Minxue Zheng, Sujuan Fei. Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00324
|
| 6 |
Leonie van Dam, Ernst J. Kuipers, Monique E. van Leerdam. Performance improvements of stool-based screening tests. Best Practice & Research Clinical Gastroenterology 2010; 24(4): 479 doi: 10.1016/j.bpg.2010.03.009
|
| 7 |
Yuriko Mori, Alexandru V Olaru, Yulan Cheng, Rachana Agarwal, Jian Yang, Delgermaa Luvsanjav, Wayne Yu, Florin M Selaru, Susan Hutfless, Mark Lazarev, John H Kwon, Steven R Brant, Michael R Marohn, David F Hutcheon, Mark D Duncan, Ajay Goel, Stephen J Meltzer. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocrine-Related Cancer 2011; 18(4): 465 doi: 10.1530/ERC-11-0083
|
| 8 |
Meng Xue, San Chuan Lai, Zhi Peng Xu, Liang Jing Wang. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review. Journal of Digestive Diseases 2015; 16(12): 699 doi: 10.1111/1751-2980.12299
|
| 9 |
Chang Woo Kim, Hyunjin Kim, Hyoung Rae Kim, Daeyeon David Won, Woo Jung Nam, Byung Soh Min, Tae Jeong Oh, Sungwhan An, Suk-Hwan Lee. A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized Trial. American Journal of Gastroenterology 2024; doi: 10.14309/ajg.0000000000003044
|
| 10 |
Andreas Herbst, Frank T. Kolligs. Detection of DNA hypermethylation in remote media of patients with colorectal cancer: new biomarkers for colorectal carcinoma. Tumor Biology 2012; 33(2): 297 doi: 10.1007/s13277-012-0346-y
|
| 11 |
Krista Marie Vincent, Lynne-Marie Postovit. A pan-cancer analysis of secreted Frizzled-related proteins: re-examining their proposed tumour suppressive function. Scientific Reports 2017; 7(1) doi: 10.1038/srep42719
|
| 12 |
Fathima Mohammed Ahamed, Asiya Nazir. Innovative Approaches for Nanobiotechnology in Healthcare Systems. Advances in Medical Technologies and Clinical Practice 2022; : 160 doi: 10.4018/978-1-7998-8251-0.ch005
|
| 13 |
Siyu He, Chenglin Zhou, Hailin Peng, Mei Lin. Recent Advances in Fecal Gene Detection for Colorectal Cancer Diagnosis. Biomarkers in Medicine 2021; 15(14): 1299 doi: 10.2217/bmm-2021-0269
|
| 14 |
Jingxin Ye, Jianfeng Zhang, Weifeng Ding. DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine. Exploration of Targeted Anti-tumor Therapy 2024; 5(1): 34 doi: 10.37349/etat.2024.00203
|
| 15 |
Janhavi R. Raut, Zhong Guan, Petra Schrotz-King, Hermann Brenner. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00904-7
|
| 16 |
CHUN-GANG HE, QIN-YUAN HUANG, LI-SHENG CHEN, ZHI-AN LING, HONG-GEN WU, HONG-QIANG DENG. p33ING1b methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. Oncology Letters 2014; 7(5): 1639 doi: 10.3892/ol.2014.1923
|
| 17 |
Xiaoyu Fan, Chunli Shi, Meng Wei, Yanqun Xiao, Xueliang Wang. External quality assessment for detection of methylated Syndecan 2 (SDC2) in China. Clinical Chemistry and Laboratory Medicine (CCLM) 2022; 60(10): 1570 doi: 10.1515/cclm-2022-0206
|
| 18 |
Patricio Órdenes, Claudio Carril Pardo, Roberto Elizondo-Vega, Karina Oyarce. Current Research on Molecular Biomarkers for Colorectal Cancer in Stool Samples. Biology 2023; 13(1): 15 doi: 10.3390/biology13010015
|
| 19 |
Qiang Xiao, Yu Yang, Xuepu Zhang, Qing An. Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion. Tumor Biology 2016; 37(5): 6315 doi: 10.1007/s13277-015-4466-z
|
| 20 |
Rongbin Liu, Xuan Su, Yakang Long, Dalei Zhou, Xiao Zhang, Zulu Ye, Jiangjun Ma, Tao Tang, Fang Wang, Caiyun He. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma. Mutation Research/Reviews in Mutation Research 2019; 779: 45 doi: 10.1016/j.mrrev.2019.01.003
|
| 21 |
Lin Wang, Ying Sun, Minghu Jiang, Shen Zhang, Stefan Wolfl. FOS Proliferating Network Construction in Early Colorectal Cancer (CRC) Based on Integrative Significant Function Cluster and Inferring Analysis. Cancer Investigation 2009; 27(8): 816 doi: 10.1080/07357900802672753
|
| 22 |
Rong-Lin Zhai, Fei Xu, Pei Zhang, Wan-Li Zhang, Hui Wang, Ji-Liang Wang, Kai-Lin Cai, Yue-Ping Long, Xiao-Ming Lu, Kai-Xiong Tao, Guo-Bin Wang. The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer. Medicine 2016; 95(5): e2129 doi: 10.1097/MD.0000000000002129
|
| 23 |
Guodong Zhao, Yong Ma, Hui Li, Shiming Li, Yun Zhu, Xiaoyu Liu, Shangmin Xiong, Yi Liu, Jin Miao, Sujuan Fei, Minxue Zheng, Xiangwei Zhao. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2. Clinica Chimica Acta 2020; 503: 84 doi: 10.1016/j.cca.2020.01.010
|
| 24 |
Linda J.W. Bosch, Frank A. Oort, Maarten Neerincx, Carolina A.J. Khalid-de Bakker, Jochim S. Terhaar sive Droste, Veerle Melotte, Daisy M.A.E. Jonkers, Ad A.M. Masclee, Sandra Mongera, Madeleine Grooteclaes, Joost Louwagie, Wim van Criekinge, Veerle M.H. Coupé, Chris J. Mulder, Manon van Engeland, Beatriz Carvalho, Gerrit A. Meijer. DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT. Cancer Prevention Research 2012; 5(3): 464 doi: 10.1158/1940-6207.CAPR-11-0315
|
| 25 |
Kim M Smits, Arjen HG Cleven, Matty P Weijenberg, Laura AE Hughes, James G Herman, Adriaan P de Bruïne, Manon van Engeland. Pharmacoepigenomics in Colorectal Cancer: A Step Forward in Predicting Prognosis and Treatment Response. Pharmacogenomics 2008; 9(12): 1903 doi: 10.2217/14622416.9.12.1903
|
| 26 |
Yoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura. New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA. Expert Review of Molecular Diagnostics 2014; 14(1): 107 doi: 10.1586/14737159.2014.863152
|
| 27 |
Shengnan Jin, Qian Ye, Yanping Hong, Wenqing Dai, Chengliang Zhang, Weihao Liu, Ying Guo, Dewen Zhu, Zhengzheng Zhang, Shiliang Chen, Yourong Wang, Dandan Li, Wen Ma, Zhengquan Yang, Jinlei Li, Zhihai Zheng, Ju Luan, Xiaoli Wu, Feizhao Jiang, Chang Xu, Chunming Ding. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers. Clinical Chemistry and Laboratory Medicine (CCLM) 2021; 59(1): 91 doi: 10.1515/cclm-2020-0300
|
| 28 |
Nasimeh Vatandoost, Jahanafrooz Ghanbari, Mahboobeh Mojaver, Amir Avan, Majid Ghayour-Mobarhan, Reza Nedaeinia, Rasoul Salehi. Early detection of colorectal cancer: from conventional methods to novel biomarkers. Journal of Cancer Research and Clinical Oncology 2016; 142(2): 341 doi: 10.1007/s00432-015-1928-z
|
| 29 |
Steven H. Itzkowitz. Stool DNA Testing for Colorectal Cancer: Development and Advances. Intestinal Research 2012; 10(2): 134 doi: 10.5217/ir.2012.10.2.134
|
| 30 |
Alexandra Kalmár, Bálint Péterfia, Péter Hollósi, Orsolya Galamb, Sándor Spisák, Barnabás Wichmann, András Bodor, Kinga Tóth, Árpád V. Patai, Gábor Valcz, Zsófia Brigitta Nagy, Vivien Kubák, Zsolt Tulassay, Ilona Kovalszky, Béla Molnár. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1687-x
|
| 31 |
M Alizade Naini, P Mokarram, S Kavousipour, N Zare, A Atapour, M Hassan Zarin, G Mehrabani, M Borji. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 2185 doi: 10.7314/APJCP.2016.17.4.2185
|
| 32 |
David A. Ahlquist. Molecular Detection of Colorectal Neoplasia. Gastroenterology 2010; 138(6): 2127 doi: 10.1053/j.gastro.2010.01.055
|
| 33 |
Keigo Yokoi, Keishi Yamashita, Masahiko Watanabe. Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer. International Journal of Molecular Sciences 2017; 18(4): 735 doi: 10.3390/ijms18040735
|
| 34 |
Mahir Gachabayov, Edward Lebovics, Aram Rojas, Daniel M Felsenreich, Rifat Latifi, Roberto Bergamaschi. Performance evaluation of stool DNA methylation tests in colorectal cancer screening: a systematic review and meta‐analysis. Colorectal Disease 2021; 23(5): 1030 doi: 10.1111/codi.15521
|
| 35 |
Jagdeep Singh Bhangu, Andrea Beer, Martina Mittlböck, Dietmar Tamandl, Walter Pulverer, Silvia Schönthaler, Hossein Taghizadeh, Stefan Stremitzer, Klaus Kaczirek, Thomas Gruenberger, Michael Gnant, Michael Bergmann, Christine Mannhalter, Andreas Weinhäusel, Rudolf Oehler, Thomas Bachleitner-Hofmann. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis. Annals of Surgery 2018; 268(5): 894 doi: 10.1097/SLA.0000000000002901
|
| 36 |
Soichiro Yamamura, Kazumori Kawakami, Hiroshi Hirata, Koji Ueno, Sharanjot Saini, Shahana Majid, Rajvir Dahiya. Oncogenic Functions of Secreted Frizzled-Related Protein 2 in Human Renal Cancer. Molecular Cancer Therapeutics 2010; 9(6): 1680 doi: 10.1158/1535-7163.MCT-10-0012
|
| 37 |
Sung Whan An, Nam Kyu Kim, Hyun Cheol Chung. Genetic and Epigenetic Marker-Based DNA Test of Stool Is a Promising Approach for Colorectal Cancer Screening. Yonsei Medical Journal 2009; 50(3): 331 doi: 10.3349/ymj.2009.50.3.331
|
| 38 |
Yaping Cao, Guodong Zhao, Mufa Yuan, Xiaoyu Liu, Yong Ma, Yang Cao, Bei Miao, Shuyan Zhao, Danning Li, Shangmin Xiong, Minxue Zheng, Sujuan Fei. KCNQ5 and C9orf50 Methylation in Stool DNA for Early Detection of Colorectal Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.621295
|
| 39 |
Linda J.W. Bosch, Beatriz Carvalho, Remond J.A. Fijneman, Connie R. Jimenez, Herbert M. Pinedo, Manon van Engeland, Gerrit A. Meijer. Molecular Tests for Colorectal Cancer Screening. Clinical Colorectal Cancer 2011; 10(1): 8 doi: 10.3816/CCC.2011.n.002
|
| 40 |
Reena Shah, Emma Jones, Victoire Vidart, Peter J.K. Kuppen, John A. Conti, Nader K. Francis. Biomarkers for Early Detection of Colorectal Cancer and Polyps: Systematic Review. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(9): 1712 doi: 10.1158/1055-9965.EPI-14-0412
|
| 41 |
Lixing Wang, Yu Liu, Duohan Zhang, Xiaoliang Xiong, Tingting Hao, Lili Zhong, Yinlong Zhao. Diagnostic accuracy of DNA-based SDC2 methylation test in colorectal cancer screening: a meta-analysis. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02395-7
|
| 42 |
Pooneh Mokarram, Mehrdad Asghari Estiar, Hassan Ashktorab. Epigenetics Territory and Cancer. 2015; : 373 doi: 10.1007/978-94-017-9639-2_13
|
| 43 |
Jesús Beltrán-García, Rebeca Osca-Verdegal, Salvador Mena-Mollá, Marta Seco-Cervera, Lorena Peiró-Chova, José Luis García-Giménez, Pierre Laurent-Puig, Andrés Cervantes. Epigenetics in Precision Medicine. 2022; : 19 doi: 10.1016/B978-0-12-823008-4.00018-4
|
| 44 |
Brian Ko, Marina Hanna, Ming Yu, William M. Grady. Cancer Epigenetics. Epigenetics and Human Health 2023; 11: 331 doi: 10.1007/978-3-031-42365-9_10
|
| 45 |
Hu Zhang, Jian Qi, Ya-Qiong Wu, Ping Zhang, Jun Jiang, Qi-Xian Wang, You-Qing Zhu. Accuracy of early detection of colorectal tumours by stool methylation markers: A meta-analysis. World Journal of Gastroenterology 2014; 20(38): 14040-14050 doi: 10.3748/wjg.v20.i38.14040
|
| 46 |
Wen-Chih Wu, Chih-Hsiung Hsu, Jen-Chun Kuan, Jih-Fu Hsieh, Chien-An Sun, Tsan Yang, Chang-Chieh Wu, Yu-Ching Chou. Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model. Genetics and Molecular Biology 2013; 36(3): 323 doi: 10.1590/S1415-47572013000300004
|
| 47 |
Stefan David, Stephen J. Meltzer. Pre-Invasive Disease: Pathogenesis and Clinical Management. 2011; : 41 doi: 10.1007/978-1-4419-6694-0_4
|
| 48 |
Dalma Müller, Balázs Győrffy. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188722 doi: 10.1016/j.bbcan.2022.188722
|
| 49 |
William M. Grady, Ming Yu, Sanford D. Markowitz. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology 2021; 160(3): 690 doi: 10.1053/j.gastro.2020.09.058
|
| 50 |
James B Rawson, Bharati Bapat. Epigenetic biomarkers in colorectal cancer diagnostics. Expert Review of Molecular Diagnostics 2012; 12(5): 499 doi: 10.1586/erm.12.39
|
| 51 |
Magdalen R.R. Carroll, Helen E. Seaman, Stephen P. Halloran. Tests and investigations for colorectal cancer screening. Clinical Biochemistry 2014; 47(10-11): 921 doi: 10.1016/j.clinbiochem.2014.04.019
|
| 52 |
Rani Kanthan, Jenna-Lynn Senger, Selliah Chandra Kanthan. Fecal Molecular Markers for Colorectal Cancer Screening. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/184343
|
| 53 |
Binnur Bagci, Musa Sari, Kursat Karadayi, Mustafa Turan, Ozturk Ozdemir, Gokhan Bagci. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients. Cancer Biomarkers 2016; 17(2): 133 doi: 10.3233/CBM-160624
|
| 54 |
Yoon Dae Han, Tae Jeong Oh, Tae-Ha Chung, Hui Won Jang, Youn Nam Kim, Sungwhan An, Nam Kyu Kim. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0642-0
|
| 55 |
Yoshinaga Okugawa, William M. Grady, Ajay Goel. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology 2015; 149(5): 1204 doi: 10.1053/j.gastro.2015.07.011
|
| 56 |
Tae Jeong Oh, Hyun Il Oh, Yang Yei Seo, Dongjun Jeong, Changjin Kim, Hyoun Woo Kang, Yoon Dae Han, Hyun Cheol Chung, Nam Kyu Kim, Sungwhan An. Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer. Clinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-017-0426-3
|
| 57 |
Giles O. Elliott, Ian T. Johnson, Jane Scarll, Jack Dainty, Elizabeth A. Williams, D. Garg, Amanda Coupe, David M. Bradburn, John C. Mathers, Nigel J. Belshaw. Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection. International Journal of Colorectal Disease 2013; 28(1): 35 doi: 10.1007/s00384-012-1532-5
|
| 58 |
Jennifer Ng, Jun Yu. Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer. International Journal of Molecular Sciences 2015; 16(2): 2472 doi: 10.3390/ijms16022472
|
| 59 |
Metin Sen, Oztürk Ozdemir, Mustafa Turan, Sema Arici, Fazilet Yildiz, Binnur Koksal, Fahrettin Goze. Epigenetic Inactivation of Tumor Suppressor SFRP2 and Point Mutation in KRAS Proto-Oncogene in Fistula - Associated Mucinous Type Anal Adenocarcinoma: Report of Two Cases. Internal Medicine 2010; 49(15): 1637 doi: 10.2169/internalmedicine.49.3249
|
| 60 |
Afsaneh Mojtabanezhad Shariatpanahi, Maryam Yassi, Mehdi Nouraie, Amirhossein Sahebkar, Fatemeh Varshoee Tabrizi, Mohammad Amin Kerachian, Osman El-Maarri. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis. PLOS ONE 2018; 13(7): e0200735 doi: 10.1371/journal.pone.0200735
|
| 61 |
R Mayor, L Casadomé, D Azuara, V Moreno, S J Clark, G Capellà, M A Peinado. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. British Journal of Cancer 2009; 100(10): 1534 doi: 10.1038/sj.bjc.6605045
|
| 62 |
Alexandra Kalmár, Bálint Péterfia, Péter Hollósi, Barnabás Wichmann, András Bodor, Árpád V. Patai, Andrea Schöller, Tibor Krenács, Zsolt Tulassay, Béla Molnár. Bisulfite-Based DNA Methylation Analysis from Recent and Archived Formalin-Fixed, Paraffin Embedded Colorectal Tissue Samples. Pathology & Oncology Research 2015; 21(4): 1149 doi: 10.1007/s12253-015-9945-4
|
| 63 |
Zhujun Xiao, Bingsheng Li, Guozhen Wang, Weisi Zhu, Zhongqiu Wang, Jinfeng Lin, Angao Xu, Xinying Wang. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms. Clinica Chimica Acta 2014; 431: 154 doi: 10.1016/j.cca.2014.01.044
|
| 64 |
C. Pox, D. Schilling. Darmkrebsprävention: Effekte der bisherigen Methoden und Perspektiven für die Zukunft. Der Gastroenterologe 2020; 15(4): 273 doi: 10.1007/s11377-020-00451-w
|
| 65 |
Linda J. W. Bosch, Sandra Mongera, Jochim S. Terhaar sive Droste, Frank A. Oort, Sietze T. van Turenhout, Maarten T. Penning, Joost Louwagie, Chris J. J. Mulder, Manon van Engeland, Beatriz Carvalho, Gerrit A. Meijer. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection. Cellular Oncology 2012; 35(4): 309 doi: 10.1007/s13402-012-0092-6
|
| 66 |
Khatere Mokhtari, Maryam Peymani, Mohsen Rashidi, Kiavash Hushmandi, Kamran Ghaedi, Afshin Taheriazam, Mehrdad Hashemi. Colon cancer transcriptome. Progress in Biophysics and Molecular Biology 2023; : 49 doi: 10.1016/j.pbiomolbio.2023.04.002
|
| 67 |
Muriel XG Draht, Robert R Riedl, Hanneke Niessen, Beatriz Carvalho, Gerrit A Meijer, James G Herman, Manon van Engeland, Veerle Melotte, Kim M Smits. Promoter CpG Island Methylation Markers in Colorectal Cancer: The Road Ahead. Epigenomics 2012; 4(2): 179 doi: 10.2217/epi.12.9
|
| 68 |
Aneta L. Zygulska, Piotr Pierzchalski. Novel Diagnostic Biomarkers in Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(2): 852 doi: 10.3390/ijms23020852
|
| 69 |
Ilze Elbere, Ivars Silamikelis, Monta Ustinova, Ineta Kalnina, Linda Zaharenko, Raitis Peculis, Ilze Konrade, Diana Maria Ciuculete, Christina Zhukovsky, Dita Gudra, Ilze Radovica-Spalvina, Davids Fridmanis, Valdis Pirags, Helgi B. Schiöth, Janis Klovins. Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals. Clinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0593-x
|
| 70 |
William M. Grady. Novel Approaches to Colorectal Cancer. Advances in Cancer Research 2021; 151: 425 doi: 10.1016/bs.acr.2021.02.006
|
| 71 |
Melina-Theoni Gyparaki, Efthimia K. Basdra, Athanasios G. Papavassiliou. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer. Journal of Molecular Medicine 2013; 91(11): 1249 doi: 10.1007/s00109-013-1088-z
|
| 72 |
Sacide Pehlivan, Mehmet Artac, Tugce Sever, Hakan Bozcuk, Can Kilincarslan, Mustafa Pehlivan. Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer. Cancer Genetics and Cytogenetics 2010; 201(2): 128 doi: 10.1016/j.cancergencyto.2010.05.019
|
| 73 |
X Zhang, X Rong, Y Chen, L Su. Methylation-mediated loss of SFRP2 enhances invasiveness of non–small cell lung cancer cells. Human & Experimental Toxicology 2018; 37(2): 155 doi: 10.1177/0960327117693071
|
| 74 |
Xuchen Zhang, Helei Hou, Man Jiang, Xiaochun Zhang. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer. Molecular Biology Reports 2023; 50(3): 2743 doi: 10.1007/s11033-022-08194-3
|
| 75 |
S. Kristiansen, G. Sölétormos. Medical Epigenetics. 2016; : 459 doi: 10.1016/B978-0-12-803239-8.00025-9
|
| 76 |
Maartje Massen, Kim Lommen, Kim A. D. Wouters, Johan Vandersmissen, Wim van Criekinge, James G. Herman, Veerle Melotte, Leo J. Schouten, Manon van Engeland, Kim M. Smits. Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers. Clinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01273-z
|
| 77 |
Barry M. Berger, David A. Ahlquist. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 2012; 44(2): 80 doi: 10.1097/PAT.0b013e3283502fdf
|
| 78 |
Alexandra Kalmár, Bálint Péterfia, Barnabás Wichmann, Árpád V. Patai, Barbara K. Barták, Zsófia B. Nagy, István Furi, Zsolt Tulassay, Béla Molnár. Comparison of Automated and Manual DNA Isolation Methods for DNA Methylation Analysis of Biopsy, Fresh Frozen, and Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Samples. SLAS Technology 2015; 20(6): 642 doi: 10.1177/2211068214565903
|
| 79 |
TEOW KOK-SIN, NORFILZA MOHD MOKHTAR, NUR ZARINA ALI HASSAN, ISMAIL SAGAP, ISA MOHAMED ROSE, ROSLAN HARUN, RAHMAN JAMAL. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data. Oncology Reports 2015; 34(1): 22 doi: 10.3892/or.2015.3993
|
| 80 |
Eivor Alette Laugsand, Siv Sellæg Brenne, Frank Skorpen. DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples. International Journal of Colorectal Disease 2021; 36(2): 239 doi: 10.1007/s00384-020-03757-x
|
| 81 |
Guro E Lind, Stine A Danielsen, Terje Ahlquist, Marianne A Merok, Kim Andresen, Rolf I Skotheim, Merete Hektoen, Torleiv O Rognum, Gunn I Meling, Geir Hoff, Michael Bretthauer, Espen Thiis-Evensen, Arild Nesbakken, Ragnhild A Lothe. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Molecular Cancer 2011; 10(1) doi: 10.1186/1476-4598-10-85
|
| 82 |
Ruth M Ayling. New faecal tests in gastroenterology. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2012; 49(1): 44 doi: 10.1258/acb.2011.011150
|
| 83 |
Sabine C. Glöckner, Mashaal Dhir, Joo Mi Yi, Kelly E. McGarvey, Leander Van Neste, Joost Louwagie, Timothy A. Chan, Wolfram Kleeberger, Adriaan P. de Bruïne, Kim M. Smits, Carolina A.J. Khalid-de Bakker, Daisy M.A.E. Jonkers, Reinhold W. Stockbrügger, Gerrit A. Meijer, Frank A. Oort, Christine Iacobuzio-Donahue, Katja Bierau, James G. Herman, Stephen B. Baylin, Manon Van Engeland, Kornel E. Schuebel, Nita Ahuja. Methylation ofTFPI2in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer. Cancer Research 2009; 69(11): 4691 doi: 10.1158/0008-5472.CAN-08-0142
|